About Us
Where it All Began
Our journey started in 2006 when our point of care technology was discovered at NPL. AgPlus was subsequently created in October 2011 to further develop and commercialize the technology for use across multiple markets.
NPL is the UK’s ‘National Measurement Institute’ and a world-leading science and research facility. They specialize in developing and applying the most accurate standards, science and technology available. To learn more about NPL please visit their website.
Point of Care testing
Global demand for excellent quantitative Point of Care testing is constantly increasing. This isn’t surprising given the aspirational goal of ‘Personalised Healthcare’, where patients are matched with the right treatment at the right time using their individual biomarker profiles.
Here at AgPlus Diagnostics our passionate team have developed a diagnostic technology platform that more than satisfies the market requirement of a fully connected, rapid quantitative PoC test for use across a wide range of clinical applications.
The technology, developed for OEM B2B solutions, provides clients with a customised assay system for rapid PoC diagnostics. The Agilis Reader can then be used across multiple applications and sectors where faster diagnostic results will enable users to make critical decisions in minutes.
Our COMPANY vision
To be a recognised global leader in innovative near patient diagnostic testing, matching each patient’s critical condition to the right treatment at the right time.
Our Mission Statement
Answering a key challenge of health services worldwide by providing accurate, cost effective near patient testing which expedites patient care and significantly reduces costs.
Our Company Values
These are the practical things we believe in and they directly inform the decisions we make and actions taken to deliver our ‘Vision’.
Patient First
Everything we do is directed to make sure that patients are in control and at the forefront of their medical care.
Customer Led
In order to support patients, we must support our B2B customers and address their business needs.
Evidence Based
Our test development has to deliver accurate results. Working with our customers, we must ensure precision and clinical evidence of efficacy.
In order to get exceptional products for patients, we need to collaborate with healthcare professional, customers, research laboratories and universities.
AGPLUS PLATFORM DEVLOPMENT
We are proud to have developed a tried and tested B2B commercial approach to Assay Development. We strive to progress partnerships including technology licensing, development plus manufacture and supply, with collaborators in a variety of applications and business sectors.
To work in conjunction with our proven assay development service, we are proud to have launched our diagnostic reader. The Agilis Reader provides a robust solution for gathering fast and quantitative data which is fully connected with a global network.
AGILIS PLATFORM
Looking for enhanced competitive edge?
We work with strategic partners to license our patent protected technology. If your organisation is interested in working with us, we’d love to hear from you.
